Cat. No.: DAA-001111
Product Information | |
---|---|
Product Name | Human Ghrelin ELISA Kit (Ghrelin-28) |
Species | Human |
Description | Human Ghrelin ELISA Kit (Ghrelin-28) is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of Ghrelin (Ghrelin-28) protein in cell culture media, cit plasma, hep plasma, and serum. It uses our proprietary ELISA technology. Quantitate Human Ghrelin (Ghrelin-28) with 1.048 pg/ml sensitivity ELISA technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our ELISA plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. |
Sample Types | Serum, Cell Culture Media, Hep Plasma, Cit Plasma |
Detection Range | 1.95 pg/mL - 125 pg/mL |
Sensitivity | 1.048 pg/mL |
Precision | CV: < 10% |
Target Information | |
---|---|
Target Name | GHRL |
UniProt No. | Q9UBU3 |
Gene ID | 51738 |
Target Description | Ghrelin is the ligand for growth hormone secretagogue receptor type 1. Induces the release of growth hormone from the pituitary. Has an appetite-stimulating effect, induces adiposity and stimulates gastric acid secretion. Involved in growth regulation.Obestatin may be the ligand for GPR39. May have an appetite-reducing effect resulting in decreased food intake. May reduce gastric emptying activity and jejunal motility. |
Alternative Names | Appetite regulating hormone; Ghrelin; Ghrelin 27; Ghrelin 28; Ghrelin and obestatin prepropeptide; Ghrelin/obestatin prepropeptide; ghrl; GHRL_HUMAN; Growth hormone releasing peptide; Growth hormone secretagogue; Growth hormone-releasing peptide; M46 protein; Motilin related peptide; Motilin-related peptide; MTLRP; Obestatin; Protein M46 |
Shipping & Storage | |
---|---|
Sipping | Shipping on dry ice. |
Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.